EMILY WHITMAN-PURVES M.D. NPI 1891012738

NPI Information

  • NPI: 1891012738
  • Provider Name: EMILY WHITMAN-PURVES, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3100 PLAZA PROPERTIES BLVD
    COLUMBUS, OH
    ZIP 43219
  • Phone: (614) 383-6000

Map and Directions

Get Directions

NPI Details

Emily Whitman-purves, M.D. is a hematology and oncology internal medicine in Columbus, OH with 16 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Emily Whitman-purves, M.D. NPI is 1891012738. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

3100 PLAZA PROPERTIES BLVD
COLUMBUS, OH
ZIP 43219-530
Phone: (614) 383-6000
Fax: (614) 383-6001

The NPI 1891012738 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Blood creatinine level (HCPCS:82565)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)

The enumeration date for this NPI number is 5/3/2010 and was last updated on 1/11/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology35-129083OHIONo
2207RH0003XInternal MedicineHematology & Oncology35-129083OHIOYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.